Product NDC: | 0187-4100 |
Proprietary Name: | Librax |
Non Proprietary Name: | Chlordiazepoxide Hydrochloride and Clidinium Bromide |
Active Ingredient(s): | 5; 2.5 mg/1; mg/1 & nbsp; Chlordiazepoxide Hydrochloride and Clidinium Bromide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0187-4100 |
Labeler Name: | Valeant Pharmaceuticals International |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA012750 |
Marketing Category: | NDA |
Start Marketing Date: | 19660901 |
Package NDC: | 0187-4100-10 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0187-4100-10) |
NDC Code | 0187-4100-10 |
Proprietary Name | Librax |
Package Description | 100 CAPSULE in 1 BOTTLE (0187-4100-10) |
Product NDC | 0187-4100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chlordiazepoxide Hydrochloride and Clidinium Bromide |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19660901 |
Marketing Category Name | NDA |
Labeler Name | Valeant Pharmaceuticals International |
Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
Strength Number | 5; 2.5 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |